Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by deepoil0808on Apr 08, 2022 4:14pm
161 Views
Post# 34589176

RE:More good news...$$$

RE:More good news...$$$Problem is that NO ONE TRUSTS THEM.

I will point out a few points:

(a)  They never told the market that they were under regulatory review, this is material news.

(b)  Imagine how disorganized the operations were when you have one (1) person processing $ 55 million in receivables and getting them rejected because they were not filled out properly.   This reaks of incompetence.

(c)  So if no money was coming in then how were they financing their payables of $ 33 million, everyone decided to work for free for months and months???  I highly doubt this.

(d) They say there is nothing they can do about stock price.   This reconfirms that their bank account is BROKE in April 2022 as they cannot even afford to buy back a 5 cent stock.

(e)  Moving to Telehealth, ya right, another 6 months to commerical sales....they have been saying this for one year, what happend to 30 software developpers the the hundreds of doctors???

(f)   Forecasting $ 200 million in sales when covid testing is dying and, when telehealth is not established.   You want me to believe it will come from Marbella pharmacy sales that barely hit $ 400,000 per year?

(g)  If you cannot make money with $ 86 million in sales, you will not make money with $ 200 million in sales.  Might as well change the corporate structure to that of a charity foundation.

Humans lie, lie, lie, numbers do not lie.    You will see first hand how many receivables are written off and how many are collected.

The fact that they cannot buy back shares tells me that they are broke and, therefore any receivables collected paid off payables and, bank account is empty.

Wish you luck

My personal opinion, 

<< Previous
Bullboard Posts
Next >>